Welcome to our dedicated page for National Vision SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for National Vision Holdings, Inc. (NASDAQ: EYE), a Delaware-incorporated optical retail company. As a Nasdaq-listed issuer, National Vision files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with other required documents. These filings offer detailed information on the company’s financial condition, risk factors, governance, and material events.
National Vision’s Form 8-K filings have covered topics such as quarterly financial results, amendments to material agreements, annual meeting voting outcomes, and changes in directors and executive officers. For example, recent 8-Ks have reported results of operations and financial condition, board and leadership changes, and an amendment to a letter agreement with a key business partner. These documents help investors track developments that the company deems material.
In its SEC reports, National Vision discusses its optical retail operations, including its store footprint, brand portfolio, and operating segments, as well as non-GAAP financial measures like Adjusted Operating Income, Adjusted Operating Margin, Adjusted Diluted EPS, and Adjusted Comparable Store Sales Growth. The filings describe how these measures are defined and reconciled to GAAP, and outline the risks and uncertainties that could affect future performance, such as competition, macroeconomic conditions, technology investments, regulatory compliance, and vendor relationships.
On Stock Titan, National Vision’s filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the key points in lengthy documents such as 10-K and 10-Q reports or detailed 8-K disclosures. Users can also review information related to governance matters, executive and director changes, and other regulatory disclosures associated with the EYE ticker.
National Vision Holdings, Inc. Chief Financial Officer Christopher Laden exercised restricted stock units that vested into common stock and used part of the shares to cover taxes. On March 31, 2026, 26,082 restricted stock units converted into 26,082 shares of common stock on a one-for-one basis.
To satisfy tax liabilities tied to this vesting, 9,702 shares were withheld at a price of $25.90 per share, leaving 16,380 shares of common stock directly held after the withholding. Following the conversion, Laden also held 70,088 restricted stock units, which continue to represent future potential shares as they vest.
The Vanguard Group filed an amendment to its Schedule 13G/A reporting for National Vision Holdings Inc. The amendment states Amount beneficially owned: 0 and Percent of class: 0%. It explains an internal realignment effective January 12, 2026 leading certain subsidiaries to report separately. The filing is signed by Ashley Grim on 03/27/2026.
National Vision Holdings, Inc. director and Chief Executive Officer Alexander Wilkes reported an open-market sale of 35,000 shares of common stock on March 11, 2026 at a weighted average price of $26.54 per share, in multiple trades between $26.21 and $26.91.
The transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on December 5, 2025, indicating it was pre-scheduled. Following this sale, Wilkes directly holds 16,431 shares of National Vision common stock.
EyePoint Pharmaceuticals notified the SEC of a proposed sale of 35,000 shares of Common Stock via Fidelity Brokerage Services LLC, with an aggregate value of $955,500.00, filed on 03/11/2026. The filing lists 34,242 shares from restricted stock vesting (08/19/2025) and 758 shares from an ESPP purchase (11/28/2025). Shares outstanding were 79,437,185 as of 03/11/2026.
National Vision Holdings, Inc. reported that Chief Technology Officer David G. Cutler acquired 10,753 restricted stock units as a grant or award. Each restricted stock unit converts into one share of common stock. Following this grant, he holds 36,750 restricted stock units directly.
According to the disclosure, one-third of these restricted stock units will vest on each anniversary of the grant date, March 6, 2026, aligning compensation with longer-term company performance and retention incentives.
National Vision Holdings, Inc. reported that senior vice president Ana Moeddel received a grant of 10,753 restricted stock units on March 6, 2026. Each restricted stock unit converts into one share of common stock. One-third of these units will vest on each anniversary of the March 6, 2026 grant date.
After this award, Moeddel directly holds 44,938 restricted stock units. These equity awards form part of her compensation and may increase her alignment with shareholder interests as the units vest over time and convert into common stock.
National Vision Holdings, Inc. executive Priti V. Patel, Head of Emerging Brands, reported equity compensation activity involving restricted stock units and common stock. On March 6, 2026, 8,224 restricted stock units were exercised and converted into 8,224 shares of common stock, consistent with the one-for-one RSU conversion described.
Patel also received a new grant of 10,753 restricted stock units on the same date. In connection with RSU vesting, 2,738 shares of common stock were disposed of at $27.90 per share to satisfy tax withholding obligations, as noted in the footnotes. After these transactions, Patel directly held 30,892 shares of common stock.
National Vision Holdings Chief Brand & Marketing Officer Joseph VanDette reported equity award activity and related tax withholding. On March 6, 2026, 8,224 restricted stock units converted into an equal number of common shares, and he received a grant of 10,753 additional restricted stock units.
After these transactions, he directly owned 48,502 shares of common stock before tax withholding. To satisfy tax obligations tied to vesting, 2,430 common shares were withheld at a price of $27.90 per share, leaving 46,072 common shares owned directly. Following the new award, he held 30,565 restricted stock units in total.
National Vision Holdings executive Mark Banner reported equity compensation activity. On March 6, 2026, 13,706 restricted stock units converted into the same number of common shares at no cost, and he received a new award of 10,753 restricted stock units. To cover tax withholding on vesting, 4,133 common shares were disposed of at $27.90 per share. After these transactions, he directly held 17,839 shares of common stock and 61,622 restricted stock units, which convert into common stock on a one-for-one basis. Footnotes indicate these units come from a 41,119-unit grant dated March 7, 2025 that vests in three equal installments starting on the first anniversary of the grant.
National Vision Holdings, Inc. Chief People Officer Bill Clark reported equity compensation activity involving restricted stock units and common stock. On March 6, 2026, 8,224 restricted stock units were exercised into common stock at no cost, and he received a new grant of 10,753 restricted stock units. Following these awards, he directly held 30,565 restricted stock units. The restricted stock units convert into common stock on a one-for-one basis and vest in three equal annual installments starting on the first anniversary of the grant date.
On the same date, 2,430 shares of common stock valued at $27.90 per share were disposed of to cover tax liabilities associated with the vesting, rather than through an open-market sale. After these transactions, Clark directly owned 70,218 shares of common stock.